To examine the potential clinical relevance of PKCγ downregulation by ΔNp63α/miR-320a axis, we first analyzed the level of ΔNp63α expression among 32 different cancer types using TCGA Pan-Cancer datasets (Fig. 8a). This evidence concerns the gene PRKCG and polyarteritis nodosa.